Examining a child on a screen is nothing like examining a child in person.
Public-health messaging and strained health-care resources during COVID-19 have meant fewer in-person exams. For some children with brain cancer, this can have devastating consequences.
Pharmaceutical companies have traditionally been the ones to develop drugs. But for rare diseases university researchers may play a role.
Developing drugs is typically the domain of large pharmaceutical companies. But here is an example of drug development for a rare pediatric brain cancer that was done in a university setting.
MRI scan of left frontal glioblastoma – an aggressive brain cancer.
When it comes to treating cancer, focus for decades has been on killing the fastest growing cells. New research finds that this approach may be too simple.
We only know if a cancer has been cured in hindsight.
Photo by Kaylee Eden on Unsplash
A cancer is in remission when it can no longer be detected. But we only say it’s cured when it hasn’t come back for a certain time – and that differs for different cancers.
All brain tumours are associated with significant sickness and death, even if they are benign.
Why hasn’t there been an improvement in survival in the last 30 years for patients with brain cancers?
Survival rates for childhood brain cancer have not improved for decades.
Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
Sen. John McCain (R-Ariz.) returned to the Capitol July 25 to cast what was a tie-breaking vote to proceed to debate a bill to repeal Obamacare.
AP Photo/Andrew Harnik
A diagnosis of glioblastoma did not keep John McCain from the Capitol to cast a crucial vote that could end Obamacare. His actions are a reminder that stats are one thing but human beings, another.
More young Australians face the daunting task of trying to live a ‘normal’ life while dealing with the after-effects of cancer.
If you’re an Australian teenager or young adult diagnosed with cancer, there’s good news: overall survival rates are good and getting better. But what can you expect from life after cancer treatment?
The well-used drug clomipramine could target tumour cells and leave normal cells healthy – if scientists could get enough evidence for it.
Time to hang up?
The evidence appears contradictory – but there may be a good reason for this.
Death rates from childhood cancer in Australia have fallen sharply.
Childhood deaths from cancer have decreased by nearly 40% in the past 15 years in Australia. But some types of childhood cancer have shown little improvement.
CT scans are expensive and carry their own risks, so a GP won’t send you for one without good reason.
A new research paper has found some cancers aren’t picked up by GPs in the first or second appointments, but it’s because cancer is usually an unlikely explanation for a patient’s symptoms.
Side effects of brain tumour treatment can impact upon academic learning.
Early intervention in neurocognition and communication can address communication and cognition difficulties in survivors of childhood brain cancer and increase their quality of life.
Complex enough – without cancer.
By tampering with the machinery which allows aggressive cancer cells to adapt, we can disrupt their ecosystem.
It’s the exceptional cases you hear about.
Studies have found that doctors often overestimate survival in terminally ill patients, not the other way round.
Speeches such as Bickmore’s should be the start of a conversation about what is funded, not its conclusion.
While I can’t fault Carrie Bickmore for trying to get attention for the disease that prematurely killed her husband, her move does raise questions about how research should be funded.
Widely proscribed around the world for its recreational uses, cannabis is being used in a number of different therapeutic ways to bring relief for severe medical conditions. Products using cannabinoids…